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Abstract
We hypothesized that the externalizing direction of the driveline (the driveline angle) at the percutaneous exit site would 
influence the occurrence of driveline infection after left ventricular assist device implantation. From August 2013 to May 
2017, 71 patients were implanted with a HeartMate II device in our center. The driveline angle was measured on anteroposte-
rior radiography just after implantation. Risk factors for driveline infection were analyzed by uni- and multivariate analyses. 
Driveline infection developed in 10 (14%) patients during follow-up. Overall actual freedoms from driveline infection at 
6, 12, and 24 months were 96%, 88%, and 86%, respectively. Overall number of driveline infection events per patient-year 
was 0.16. Receiver operating characteristic analysis determined the cut-off point of the driveline angle as 41°. The 6-, 12-, 
and 24-month actuarial freedoms from driveline infection in those with driveline angle more than 42° (84%, 74%, and 74%, 
respectively) were significantly lower than in those with driveline angle less than 41° (97%, 94%, and 90%, respectively; 
p < 0.02). The numbers of driveline infection events per patient-year were 0.16 in patients with driveline angle more than 
42°, and 0.04 in patients with driveline angle less than 41°. Multivariate analysis demonstrated that driveline angle more than 
42° was an independent risk factor for driveline infection (hazard ratio 4.71). Driveline angle more than 42° is an independ-
ent risk factor for driveline infection in patients with HeartMate II. Externalization of the driveline toward the horizontal 
direction is important to prevent driveline infection with HeartMate II.
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Introduction
Implantation of a left ventricular assist device (LVAD) is 
now a standard treatment for advanced heart failure in west-
ern countries. However, complications related to long-term 
LVAD support are one of the major hurdles that need to be 
overcome to establish the LVAD as the destination therapy 
in many countries, including Japan. Major LVAD-related 
complications include cerebrovascular accident, hemolysis, 
right-sided heart failure, bleeding, device failure, and drive-
line infection [1–3]. Driveline infection is an unavoidable 
complication in the contemporary LVAD system in which 
the main power battery is located outside the body, and 
the reported prevalence of driveline infection is 0.07–0.58 
events per patient-year [4, 5]. Local infection around the 
driveline exit site can extend to the main pump or the out-
flow graft, finally developing into a fatal systemic infection.
Driveline infection of the HeartMate II device is report-
edly substantially reduced when the entire driveline velour 
portion is left below the skin [6]. Another factor influencing 
the degree of driveline infection is the type of LVAD [7, 
8]. Moreover, local infection around the driveline may be 
induced by passive movement of the driveline exit, which 
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might impair firm attachment of the driveline surface to 
the subcutaneous tissue [9, 10]. These factors suggest that 
susceptibility to or extendability of driveline infection is 
determined by the nature of the driveline, condition of the 
immunologic barrier, and interaction between the driveline 
and the skin tissue. We hypothesized that the externalizing 
direction of the driveline at the percutaneous exit site would 
influence the prevalence of driveline infection after LVAD 
implantation. The present study aimed to explore the rela-
tionship between the driveline angle and driveline infection 
in patients with implantable LVAD.
Materials and methods
Study cohort and data collection
Data were collected from a prospective, institutional, sur-
gical database that contained a consecutive series of 90 
patients in whom a LVAD was implanted as a bridge-to-
transplantation in the National Cerebral and Cardiovascular 
Center Hospital between August 2013 and May 2017. In this 
institute, HeartMate II (Abbott Laboratories, Chicago, IL, 
USA) had consistently been the primary choice of implanta-
ble LVAD and was implanted in 71 of the 90 patients (79%); 
these 71 patients comprised the cohort of the present study 
(Table 1). Data were collected from medical charts, opera-
tion reports, and referral letters, and were further supple-
mented by telephone interviews with those patients under 
the care of physicians outside of our institution. Data col-
lection was performed in August 2017. The follow-up rate 
at July 2017 was 100%, and the mean follow-up period was 
1.9 ± 1.1 years. Complications were defined according to 
the adverse event definitions of the Interagency Registry for 
Mechanically Assisted Circulatory Support (INTERMACS) 
[11].
Ethical approval
All patients provided written informed consent for surgery, 
and for the use of their data for diagnostic and research pur-
poses prior to the surgery. The institutional review board 
approved the present retrospective study and waived the 
need for patient consent.
Surgical indication and procedure
Indication for LVAD implantation was preoperatively deter-
mined by the institutional heart team comprising cardiolo-
gists, cardiac surgeons, transplant physicians, and associ-
ated co-medical staff, in accordance with current guidelines 
[12, 13]. As all of the patients in the present cohort were 
listed, transplant candidates, patients with malignancy or 
psychiatric problems had already been excluded (Table 1). 
The surgical procedure of HeartMate II implantation was 
consistent throughout the study period, apart from the exter-
nalization point of the driveline. The driveline externaliza-
tion point was determined by the heart team and was marked 
1 day prior to the surgery. Until October 2015, the drive-
line was externalized at the right upper quadrant (n = 37), 
whereas the left upper quadrant was used from December 
2015 onwards. The right-sided externalization of the drive 
was made via a single tunnel through the right upper rectus 
muscle, whereas the left-sided externalization was made 
using the double-tunnel technique in which the driveline 
penetrating the first tunnel through the right upper rectus 
muscle was turned horizontally into the left side through the 
subcutaneous tissue. The velour portion of the driveline was 
entirely buried under the skin in all cases.
Postoperative care
During postoperative recovery, driveline care education 
was given to all patients and their caregivers until they 
demonstrated satisfactory care skills. After discharge from 
the hospital, driveline care was performed by the patients 
themselves or their caregivers. The driveline was secured 
by an anchoring device such as a Foley Anchor (Centurion, 
Table 1  Patient characteristics
Data are presented as number (%) or mean ± standard deviation
BNP brain natriuretic peptide, eGFR estimated glomerular filtration 
rate, INTERMACS Interagency Registry for Mechanically Assisted 
Circulatory Support
n = 71
Male, no. (%) 52 (73%)
Age, years 45 ± 13
Body surface area,  m2 1.6 ± 0.2
Body mass index, kg/m2 21.2 ± 4.3
Thickness of abdominal fat (cm) 1.7 ± 0.9
Dilated cardiomyopathy, no. (%) 42 (59%)
Dilated phase of hypertrophic cardiomyopathy, no (%) 9 (13%)
Fulminant myocarditis 5 (7%)
Ischemic etiology, no. (%) 8 (11%)
Previous extracorporeal LVAD implantation, no. (%) 11 (16%)
INTERMACS profile 2, no (%) 28 (40%)
INTERMACS profile 3, no (%) 42 (60%)
Total bilirubin (mg/dl) 1.2 ± 1.0
Creatinine (mg/dl) 1.0 ± 0.3
Albumin (g/dl) 3.8 ± 0.5
Cholinesterase (U/l) 225 ± 73
BNP (pg/ml) 717 ± 655
eGFR (ml/min/1.73 m3) 90 ± 105
Support month 20 ± 14
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Mundelein, IL). Dressing materials were chosen in accord-
ance with the condition of the exit site and the skin, with a 
dressing change performed every 2–3 days in accordance 
with the patients’ conditions. All patients visited the institu-
tional outpatient clinic fortnightly or monthly to be reviewed 
by physicians and co-medical staff, including a review of the 
exit site care.
Data for driveline infection were retrieved from the elec-
trical medical chart, which included a photograph of the exit 
site. Driveline infection was identified based on a positive 
bacterial culture obtained from the skin and/or tissue sur-
rounding the driveline, coupled with the need for antimicro-
bial therapy in patients with clinical evidence of infection, 
such as pain, fever, exudation, or leukocytosis, in accordance 
with the INTERMACS definition of percutaneous site infec-
tion. We made a diagnosis of driveline infection at the initia-
tion of antimicrobial therapy or having a result of positive 
bacterial culture. Patients without positive bacterial culture 
or antimicrobial therapy, even with wet exit site and pain, 
were excluded from driveline infection. In addition, antimi-
crobial therapy, surgical debridement or driveline transloca-
tion was performed in cases with deep driveline infection 
in which the infection extended more than 3 cm from the 
exit site, as diagnosed by plain CT or Ga-67 scintigraphy. 
Driveline translocation is a procedure used to create a new 
exit site, in which the infected tissue is debrided by cutting 
the skin and subcutaneous tissue along with the driveline 
back to the intact portion of the driveline.
Measurement of the driveline angle
The driveline angle was defined as the angle between a tan-
gential line at the driveline exit site and a horizontal line; 
this was measured on an anteroposterior radiography in the 
supine position 1 day after LVAD implantation (Fig. 1). 
Routine radiography showed that the driveline angle did not 
change throughout the study period in any patient.
Statistical analysis
Data are presented as the mean ± standard deviation for con-
tinuous variables, and as percentages for categorical vari-
ables. Differences between groups were analyzed with the χ2 
test or the Student’s t test, with p < 0.05 considered statisti-
cally significant. Uni- and stepwise multivariate analyses 
based on the Cox proportional hazard model were used to 
determine associations between pre- or intraoperative factors 
and driveline infection. The cut-off point for the driveline 
angle was determined by receiver operating characteris-
tics (ROC) analysis. Freedom from driveline infection was 
evaluated via Kaplan–Meier actuarial analysis; comparisons 
between groups were made using the log-rank test. Statisti-
cal analyses were performed with EZR (Saitama Medical 
Center, Jichi Medical University, Saitama, Japan), which is 
a graphical user interface for R (The R Foundation for Sta-
tistical Computing).
Results
Early results of HeartMate II implantation
A HeartMate II device was implanted in 71 patients as a 
bridge-to-transplantation between August 2013 and May 
2017. There was one in-hospital death due to multiple 
organ failure attributed to severe right-sided heart failure. 
In-hospital major complications related to HeartMate II 
implantation included chest re-exploration for bleeding in 11 
patients (15%), cerebrovascular accidents in 11 (15%), drive-
line infection in two (3%), major hemolysis in two (3%), 
right-sided heart failure in two (3%), and rapid progression 
of aortic insufficiency in one (1.4%).
Long‑term results of HeartMate II implantation
Clinical follow-up was completed in all 71 patients 
who underwent HeartMate II implantation. Fifteen 
patients successfully underwent cardiac transplanta-
tion at 25 ± 8 months post-HeartMate II implantation, 
while 54 patients were awaiting cardiac transplantation 
at the end of July 2017. The remaining two patients died 
prior to transplantation, due to right-sided heart failure 
Fig. 1  Illustration of the driveline angle as the angle between a tan-
gential line at the driveline exit site and a horizontal line, measured 
on anteroposterior radiography
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or cerebrovascular accident at 41 days and at 3.1 years 
after HeartMate II implantation, respectively. By the end 
of follow-up, 53 patients (76%) had experienced major 
complications, such as driveline infection, major bleed-
ing, cerebral vascular accident, major hemolysis, major 
device malfunction, right-sided heart failure, and/or aortic 
insufficiency.
Driveline infection: frequency and treatment
Overall, 10 (14%) patients developed driveline infection 
during follow-up. Bacterial culture of the exit site identi-
fied methicillin-sensitive Staphylococcus aureus in four 
patients, and methicillin-resistant S. aureus in five, despite 
preoperative decolonization by nasal mupirocin ointment. 
Of these ten patients, two developed the driveline infec-
tion in hospital, while the average interval between LVAD 
implantation and diagnosis of the first driveline infection 
in the remaining eight patients was 9.4 (1.0–26.8) months. 
Overall actual freedom from driveline infection was 96% 
at 6 months, 88% at 12 months, and 86% at 24 months 
(Fig. 2).
Of the 10 patients with driveline infection, five (50%) 
underwent surgical debridement for deep driveline infec-
tion in hospital after intensive systemic and local antibiotic 
treatments. Of these five patients, two underwent surgical 
translocation of the driveline; the infected exit site tissue 
was debrided, and then a longitudinal skin incision was 
made along the driveline until the intact portion of the 
driveline appeared, where a new exit site was created. As 
a result, no patient required LVAD exchange for pump 
pocket infection extending from driveline infection.
Risk factors associated with driveline infection
The results of the uni- and multivariate analyses of risk 
factors associated with driveline infection are summarized 
in Table 2. Driveline angle was identified as an independ-
ent risk factor for driveline infection (hazard ratio 1.03, 
p = 0.03). The side that the exit site was located on (covari-
ate or double-tunnel technique) and the period during which 
the operation was performed (early: April 2014–Septem-
ber 2015, or late: October 2015–March 2017) were not 
independent risk factors for driveline infection. The ROC 
analysis determined the cut-off point of the driveline angle 
as 41° (Fig.  3a). The respective 6-, 12-, and 24-month 
actuarial freedoms from driveline infection in the patients 
with a driveline angle more than 42° (84%, 74%, and 74%, 
respectively) were significantly lower than those of the 
patients with a driveline angle < 42° (97%, 94%, and 90%, 
respectively; p < 0.016) (Fig. 3b). The numbers of driveline 
infection events per patient-year were 0.16 in patients with 
a driveline angle more than 42°, and 0.04 in patients with a 
driveline angle less than 41°. Further uni- and multivariate 
analyses based on the Cox proportional hazard model dem-
onstrated that driveline angle more than 42° as a categorical 
value was an independent risk factor for driveline infection 
(hazard ratio 4.71).
Discussion
We reviewed a consecutive series of 71 patients who had 
undergone HeartMate II implantation as a bridge-to-trans-
plantation in a single institution since 2013, which was when 
this device was approved for marketing in Japan. Major 
adverse events post-HeartMate II implantation included 
major bleeding in 43 patients, cerebrovascular accidents 
in 15, device malfunction in seven, device-related major 
hemolysis in five, right-sided heart failure in six, and drive-
line infection in ten. Of the ten patients with driveline infec-
tion, five underwent surgical debridement of the infected exit 
site. Driveline angle was the sole independent risk factor for 
driveline infection in the present series, and the cut-off value 
of the driveline angle was 41°.
Although HeartMate II was implanted only as a bridge-
to-transplantation in Japan, the very long waiting time in 
Japan for transplantation time dependently worsens patient 
quality of life during HeartMate II support due to a variety 
of complications represented by driveline infection. A previ-
ous study evaluating the INTERMACS registry reported that 
the prevalence of driveline infection was 19% at 12 months 
after LVAD implantation [8]. The present results (12% 
Fig. 2  Overall actual rates of freedom from driveline infection at 6, 
12, and 24 months were 96%, 88%, and 86%, respectively
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prevalence of driveline infection at 12 months) were consist-
ent with this previous report [8], despite the differences in 
characteristics or postoperative care of the cohorts, suggest-
ing that the surgical and medical treatment protocols of the 
contemporary LVAD have nearly been standardized. How-
ever, our contemporary method of driveline externalization, 
in which the driveline exits horizontally at an angle of less 
than 42°, led to a driveline infection prevalence of only 6% at 
Table 2  Uni- and multivariate 
Cox proportional hazard 
analyses of variables associated 
with driveline infection
Data are presented as number (%) or mean ± standard deviation
BNP brain natriuretic peptide, BMI body mass index, BSA body surface area, eGFR estimated glomerular 
filtration rate, INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support
Covariate Univariate Multivariate
Hazard ratio 95% CI p value Hazard ratio 95% CI p value
Age (years) 0.98 0.93–1.03 0.35
Sex male None value 0–Inf 0.99
INTERMACS profile 2.08 0.45–9.53 0.35
BMI (kg/m2) 1.01 0.88–1.17 0.89
BSA  (m2) 9.56 0.34–270 0.19
Albumin (g/dl) 1.09 0.29–4.19 0.9
Abdominal fat (cm) 1.13 0.56–2.31 0.73
Cholinesterase (U/l) 0.99 0.99–1.01 0.36
Creatinine (mg/dl) 1.91 0.32–11.4 0.48
eGFR (ml/min/1.73 m3) 0.99 0.98–1.01 0.61
Total bilirubin (mg/dl) 1.33 0.71–2.48 0.37
BNP (pg/ml) 0.99 0.99-1.00 0.33
Double-tunnel technique 0.24 0.03–1.98 0.18
Late period (2015/10–2017/3) 0.2 0.02–1.68 0.14
Right side exit site 4.2 0.51–35 0.18
Driveline angle (°) 1.03 1.00–1.06 0.03 1.03 1.00–1.06 0.04
Re-exploration for bleeding 3.2 0.9–11.4 0.07 2.77 0.78–9.85 0.12
Fig. 3  a Receiver operating characteristics analysis determined that 
the cut-off point of the driveline angle was 41°. The area under the 
curve was 0.86 (sensitivity 0.86, specificity 0.78). b The respec-
tive 6-, 12-, and 24-month actuarial rates of freedom from driveline 
infection in the patients with a driveline angle more than 42° (84%, 
74%, and 74%, respectively) were significantly lower than those of 
the patients with a driveline angle less than 41° (97%, 94%, and 90%, 
respectively; p = 0.016)
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12 months. Moreover, our method led to a driveline infection 
prevalence of 10% at 24 months, which is substantially better 
than the previously reported driveline infection prevalence 
after LVAD implantation [8]. This noticeable improvement 
in the prevalence of driveline infection may be explained 
by the theory that the attachment of the driveline at the exit 
site is the major determinant of driveline infection [6, 9]. 
We consider that horizontal externalization towards the left 
using the double-tunnel technique would be the most con-
sistent method with which to achieve immobilization of the 
driveline at the exit site, which is a prerequisite to wound 
healing along the subcutaneous route [9].
We consider that the most substantial factor affecting the 
driveline angle at the driveline exit site is the stability of 
the local site. A wider driveline angle (a driveline angled 
in a vertical and caudal direction) tends to enable the drive-
line to move in and out of the exit site, or to be interfered 
with by the lower part of the body or waist during somatic 
movements (such as sitting up, bending down, crouching, 
sitting on a chair or bed, and taking off and putting on trou-
sers), which are common actions performed during daily 
activity; in contrast, a smaller driveline angle (a driveline 
externalized in a horizontal direction) can remain relatively 
immobile during the abovementioned body motions. Fur-
thermore, the point at which the side of the body contacts the 
surface of the driveline at the exit site can be difficult to see 
with a vertically directed driveline; subsequently, this area 
may not be completely cleaned during daily care, whereas 
with a horizontally directed driveline, this area is visible 
to the patient, and can be more easily cleaned. Therefore, 
the smaller driveline angle (horizontally directed driveline) 
would lead to stability of the driveline exit site and facilita-
tion of adequate topical care, resulting in a lower incidence 
of driveline exit site infection, even in our relatively young 
population.
We also tried to figure out other factors potentially 
related to driveline infection, such as wound care method, 
frequency of dressing change, frequency of medical con-
sultation, outpatient clinic visits and body weight gain. We 
consistently managed wound in dry condition, utilizing 
moisture-permeable film dressing in all patients in this 
study. In case of wet wound condition with or without 
evidence of driveline infection, patients were advised to 
increase frequency in dressing change. We encouraged 
frequent dressing change in warm and sweaty season to 
keep wound dry. In cases with unfavorable wound condi-
tion, regardless of reasons, frequency of outpatient clinic 
increased. Therefore, we could not conclude relationship 
between driveline infection and exit site care method, 
frequency of dressing change or outpatient clinic visit. 
Among ten patients with driveline infection, only one 
patient developed driveline infection subsequently to body 
weight gain. Although patients with increased body weight 
and abdominal fat tend to develop instable or wet exit site, 
fortunately little patients in our cohort developed to posi-
tive bacterial culture.
It should be noted that the use of the double-tunnel tech-
nique with a left-side exit site did not significantly influ-
ence driveline infection in the present study. However, we 
still consider that the current double-tunnel technique with 
a left-side exit site is the most effective method to prevent 
driveline infection for two reasons. First, Japanese patients 
generally have a relatively small body size, which makes it 
difficult to achieve a driveline angle of less than 42° when 
using a right-side exit site. Second, compared with a right-
side exit site, a left-side exit site would be easier to access 
and care for in right-handed patients, which comprise the 
great majority in the Japanese population. Additionally, a 
longer subcutaneous attachment in the left-side exit site 
may contribute to better stability of the exit site. However, 
according to multiple analyses including the side of exit site, 
the left-side exit site was excluded by stepwise multivariate 
Cox proportional hazard analysis. We did not measure the 
length of the buried portion of driveline. Therefore, inde-
pendent impact of the length of the buried portion of the 
driveline should be investigated in further large-size study.
Our population had a lower incidence of driveline infec-
tion compared with that reported in the INTERMACS reg-
istry. Apart from the driveline angle, the good long-term 
outcome in the present series may have been influenced 
by our excellent care protocol, including patient education 
for self-care of the exit site, management of anticoagulant 
therapy using CoaguCheckR (Roche Diagnostics Interna-
tional, Basel, Schweiz), handling of the device, and how 
to deal with device alarms. Our good results might also 
have been influenced by our use of antibiotic prophylaxis 
for methicillin-resistant S. aureus, Gram-negative bacteria, 
and fungi [14].
The present study was limited by its retrospective nature 
in a single institute, with a small cohort of patients only 
implanted with HeartMate II devices. Furthermore, the 
reproducibility of the influence of the driveline angle on the 
disruption of tissue ingrowth at the exit site was not proven 
histologically. Further investigation to verify the mecha-
nism is warranted. We could not figure out the impact of 
frequency of dressing change, medical consultation and side 
of exit site. Sole influence of such factors should be investi-
gated. Moreover, the present findings should be confirmed 
with other implantable LVADs.
In conclusion, driveline angle more than 42° was an inde-
pendent risk factor for driveline infection in patients with 
HeartMate II. Externalization of the driveline toward the 
horizontal direction is important to prevent driveline infec-
tion of HeartMate II devices. The concept of driveline sta-
bility with adequate externalization at the exit site is very 
important for long-term durable driveline care.
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